Thermo Fisher Scientific

Thermo Fisher Scientific

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Market Cap: $182.6BPipeline: 9 drugs (1 Phase 3)Patents: 20Founded: 2006Employees: >130,000HQ: Waltham, United States

Overview

Thermo Fisher Scientific's mission is to enable its customers to make the world healthier, cleaner, and safer by providing the scientific tools and services that accelerate innovation. The company has achieved a dominant market position through strategic acquisitions, organic innovation, and the creation of an unparalleled, integrated ecosystem for the scientific community. Its strategy revolves around leveraging its scale and breadth to drive operational excellence, investing in high-growth areas like bioproduction and precision medicine, and selectively advancing an internal pipeline of novel therapeutics. With a market capitalization exceeding $178 billion, Thermo Fisher is a foundational pillar of the global life sciences industry.

OncologyAutoimmune DisordersMetabolic DiseasesNeuroscience

Technology Platform

A comprehensive, industry-leading suite of platforms spanning high-resolution mass spectrometry (Orbitrap), next-generation sequencing (Ion Torrent), cell culture and gene editing (Gibco, Invitrogen), chromatography, electron microscopy (including cryo-EM), and integrated biopharma production services.

Pipeline

9
9 drugs in pipeline1 in Phase 3